header-logo
Ophthalmology_Hero Image 2
Ophthalmology and Visual Sciences

 Medical College of Wisconsin Ophthalmology and Visual Sciences Research Study - MacTel SAFE

Purpose of study:
This project is being done so that scientist can study the effects of the drugs serine and fenofibrate on lipids (fats) in the blood of people affected with MacTel Type 2. Patients with MacTel type 2 tend to have increased lipid levels and we want to see if these drugs can help reduce these lipids.

What is Macular Telangiectasia Type 2?
Macular telangiectasia type 2 (MacTel) is an age-related condition of the macula that effects both eyes and may cause progressive loss of vision.

What is involved in this project?
To enroll in this project, you must already be or also enroll into the “MacTel Natural History Observation and Registry for MacTel Type2” project.

The SAFE study will last 11 weeks with 5 visits occurring at the Eye Institute. During these visits we will ask general questions about your medical history, medications you are on, complete blood draws and we may also take a few images of the back of your eye.

If you are enrolled, you will have an equal chance of being assigned either the drug serine or fenofibrate or both. You may also be assigned to receive no drug. You will be told what drug you are receiving.

Compensation:
Research volunteers will be compensated $50 for the completion of each study visit. In specific circumstances, reasonable travel expense reimbursement may be provided with the sponsor’s approval. If you have questions about whether or not you will be reimbursed for travel, please speak with your study doctor.

You may be eligible to participate in the study if you meet these criteria:

  1. You are 21 years or older.
  2. You have been told by a doctor that you have Macular Telangiectasia Type 2
  3. You are enrolled in the MacTel Natural History Observation and Registry for MacTel Type2” project or willing to enroll
  4. You are not currently taking a serine or glycine supplement or an anticoagulant
  5. You are not currently taking or have recently taken a fibrate drug

More Information:
IRB Approval: PRO41070, 1/10/2022

Research Volunteer Form

Please select an option below.

Your Information

Please answer Yes or No to the following questions.

Additional Information

By submitting this form, I acknowledge that I would like to be contacted about the MacTel SAFE project and understand that submission of this form in no way obligates me to participate in this study.

We will contact you as soon as we can. Thank you for your patience.

If you have questions, please contact Amber Irons at airons@mcw.edu or (414) 955-2031.

Contact Ophthalmology

For patient care inquires, call us at (414) 955-2020 or use MyChart. Email is for research and education inquiries only.

Eye Institute Location

925 N. 87th St.

Milwaukee, WI 53226

 

Appointments

(414) 955-2020

(414) 955-6166 (fax)

 

Continuing Medical Education

Amanda Tan

atan@mcw.edu

(414) 955-2049

 

Medical Education Coordinator

Ophth-Residency@mcw.edu

 

Associate Director of Development - Ophthalmology

Sarah Walker

sarawalker@mcw.edu

Refer to Us - Consultation requests

Patient Referral Form (PDF)

Fax to (414) 955-0136

 

Emergent Requests

Within 48 hours call

(414) 955-2020

 

Research

Vesper Williams

vewilliams@mcw.edu

(414) 955-7862

 

Advanced Ocular Imaging Program

aoip@mcw.edu

(414) 955-2647

 

Eye Institute Executive Director (Administrator)

Shannon Dreier

sdreier@mcw.edu

Eye Institute Google map location

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The Medical College of Wisconsin is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.